1. Home
  2. PAYO vs ATAI Comparison

PAYO vs ATAI Comparison

Compare PAYO & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$7.04

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.59

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYO
ATAI
Founded
2005
2018
Country
United States
United States
Employees
2540
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
PAYO
ATAI
Price
$7.04
$4.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
8
Target Price
$7.69
$15.88
AVG Volume (30 Days)
12.4M
5.3M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,089,000.00
Revenue This Year
$7.15
N/A
Revenue Next Year
$10.28
N/A
P/E Ratio
$30.36
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$4.08
$2.15
52 Week High
$7.67
$6.73

Technical Indicators

Market Signals
Indicator
PAYO
ATAI
Relative Strength Index (RSI) 79.17 62.27
Support Level $4.78 $3.47
Resistance Level N/A $4.68
Average True Range (ATR) 0.23 0.32
MACD 0.06 0.04
Stochastic Oscillator 95.70 78.60

Price Performance

Historical Comparison
PAYO
ATAI

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: